Neurorehabilitation Devices Market
Global Industry Analysis and Forecast 2023-2030
Market Value (2022)
USD 1.96 Billion
Forecasted Value (2030)
USD 5.63 Billion
CAGR (2023 - 2030)
Fastest Growing Region (2023 - 2030)
Neurorobotic Systems, Brain-computer Interface, Wearable Devices, Brain Stimulators
Stroke, Brain & Spinal Cord Injury, Parkinson’s Disease, Cerebral Palsy • Multiple Sclerosis • Others
By End User
Rehabilitation Centers, Hospitals & Clinics, Home Care, Others
The global Neurorehabilitation Devices Market was valued at USD 1.96 billion in 2022 and is projected to reach USD 5.63 billion by 2030, growing at a CAGR of 14.32% from 2023 to 2030.
The increased demand for neurorehabilitation devices to help patients recover from injuries caused by neurological diseases such as Parkinson's disease, traumatic brain injury, and stroke has augmented market growth. The development of new devices such as robotics and brain-computer interface, has led to more effective and efficient rehabilitation methods. These advances have increased the market growth among both patients and healthcare providers. Governments around the world are investing in the development of neurorehabilitation devices to improve the quality of life of patients suffering from neurological diseases. The market size is expected to grow in the coming years due to these influencing factors and the increasing prevalence of neurological disorders across the globe. However, the high cost of equipment and regulatory barriers hampers the market growth. The cost of these devices can be prohibitively expensive, which is the most significant constraint to their widespread clinical application.
Analyst’s Review on Neurorehabilitation Devices Market
Recent innovations in neurorehabilitation devices have driven market growth forward, helping patients recover from neurological disorders and improve their quality of life. These innovations range from brain-computer interfaces to robotics, wearables, and stimulation devices. Wearable devices are also becoming increasingly popular on the neurorehabilitation devices market. Patients can use wearable devices such as exoskeletons to support and assist them in various tasks. In addition to these specific innovations, broader trends are also driving the development of neurorehabilitation devices. With continued investment and collaboration, we have expanded to develop devices that are more effective, affordable, and easier to use, ultimately improving the quality of life for patients with neurological disorders.
Neurorehabilitation devices are medical equipment and devices used to rehabilitate patients with neurological diseases such as stroke, traumatic brain injury, and spinal cord injury. They are designed to help patients regain their physical and cognitive abilities and improve their quality of life. These devices are especially useful for patients with mobility impairments who need help moving or performing daily activities. It can improve brain plasticity and help patients use their motor and cognitive skills.
The aging population, lifestyle changes, and an increase in risk factors such as hypertension, obesity, and diabetes have contributed to an increase in the incidence of neurological disorders. In addition, neurorehabilitation devices, including those designed to treat stroke, tremors, and other conditions, play a critical role in assisting patients to recover from injuries and improve their quality of life. Moreover, addressing the growing incidence of neurological disorders worldwide requires a multifaceted approach that includes R&D activities of innovative treatments and technologies, public awareness and government policy, and investment in health resources. The governments across the region strive to enhance access to care and treatment for patients living with neurological illnesses, as well as to prevent new cases and promote brain health and development throughout life.
The market growth is proliferating rapidly owing to the increased availability of various forms of devices designed to address the different needs of the end users including patients, caregivers, and clinicians. However, these devices can be expensive to develop, manufacture and maintain which can be a barrier for patients, especially those who may be uninsured or underinsured. In addition, the high cost of these devices may limit the number of healthcare facilities that offer them, which may also limit patient access. Despite these challenges, efforts are underway to address the high cost of neurorehabilitation devices. Some innovative companies and researchers are focusing on developing cheap and reconfigurable neurorehabilitation robots that could increase the accessibility of these devices. Additionally, some health systems are exploring alternative payment models, such as value-based care, to ensure that patients receive the most effective treatment for their conditions at affordable prices.
The global neurorehabilitation devices market is segmented based on product, application, and geography.
Based on product, the market is classified into neurorobotic systems, brain-computer interfaces, wearable devices, and brain stimulators. The neurorobotic systems is the dominating segment which generated a market share of 39.32% in 2022. The market for neurorobotic systems is expanding as these technologies connect robotic equipment with accurate biological simulations of the brain. Neurorobotics combines robotics, neurosciences, and machine learning. Recent breakthroughs, such as exoskeletons and prostheses, have substantially aided neurorobotics in this area which accelerates the segment growth.
Based on application, the neurorehabilitation devices market is segmented into stroke, brain & spinal cord injury, Parkinson’s disease, cerebral palsy, multiple sclerosis, and others. The stroke segment registered high growth, with a market share of 37.56% in 2022. The stroke segment is growing as people with lifestyle diseases and an aging population are more vulnerable to suffering from stroke. The high incidence and prevalence of mobility problems are the primary causes of stroke, which accelerates the need for neurorehabilitation devices.
Based on end user, the neurorehabilitation devices market is categorized into rehabilitation centers, hospitals & clinics, home care, and others. The hospitals & clinics is the dominating segment owing to the increased outflow of patients combined with the rising number of services offered on the ground. Furthermore, consumers are focused on raising their medical treatments spending, which is predicted to strengthen the segmental growth.
Based on regional analysis, the global neurorehabilitation devices market is classified into North America, Europe, Asia Pacific, MEA, and Latin America.
North America is growing rapidly with a market share of 41.13% in 2022. The regional growth is driven mainly due to the increasing prevalence of neurological diseases such as stroke, traumatic brain injury, and others. The aging population of North America is contributing to an increase in neurological disorders which requires neurorehabilitation devices that help patients recover from their condition and improve their quality of life. Several companies and researchers across the region are focusing on developing advanced products including robotics, telemedicine, and virtual reality technologies. Furthermore, there is a substantial need for neurorehabilitation devices in North America, and it is essential that health systems and governments coordinate to ensure that these devices are available and affordable for all patients, which promotes neurorehabilitation devices market growth.
The neurorehabilitation devices market in the Asia Pacific region is the fastest-growing region with a market share of 20.24% in 2022. There is a growing need for neurorehabilitation devices in the Asia-Pacific region, especially due to the use of these devices to aid in the rehabilitation and recovery of patients suffering from neurological diseases. The ongoing research focuses on improving device performance, optimizing patient outcomes, and exploring innovative technologies in the fiefostering the regional growth of the market. Mobile health apps are gaining popularity in Asia for neurorehabilitation, these applications, along with mobile devices, can aid in remote monitoring, patient engagement and personalized neurorehabilitation therapy. For instance, in June 2020, the Morrison government invested USD 21.8 million in vital research that focuses on the treatment of a range of neurological diseases, including early-onset Alzheimer's, autism, and encephalitis. The increased governmental efforts towards the treatment of neurological disorders further foster the demand for neurorehabilitation devices across the region.
The global neurorehabilitation devices industry study report will provide valuable insight with an emphasis on the fragmented nature of the global market. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their respective market shares across different regions. Development & investments involve a range of strategic initiatives including investments in R&D activities, new manufacturing facilities, and supply chain optimization. The major players in the market are
- AIMedical International Pty Ltd
- Ekso Bionics
- Evolution Devices
- Gloreha IDROGENET s.r.l.
- Helius Medical Technologies, Inc.
- Neurofenix, Inc.
- Sumitomo Pharma Co., Ltd.
- February 2023 (Product Launch): MindMaze launched Izar, which is US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral device for patients with impaired hand motor skills. Izar is designed to fill a critical gap in neurological care and aims to be the most effective treatment for manual dexterity and strength in a wide range of neurological conditions.
- September 2021 (Product Launch): Evolution Devices launched EvoWalk Platform pilot program to restore walking to those with neurological partial ambulatory paralysis. The company's approach is designed to combine neurological remote physical therapy (PT) with EvoWalk, a smart stimulation device that helps patients avoid falls and restore instinctive movements.
- September 2022 (Partnership): Sumitomo Pharma Co., Ltd. and MELTIN MMI entered into an agreement with MELTz for marketing the MELTz product primarily in rehabilitation units to recover. This device is designed to support hand/finger motor function rehabilitation by combining algorithms that recognize myoelectric (biosignals) hand/finger movement signals with a robotic system that provides motor assistance based on the intended movements of the user.
The global Neurorehabilitation Devices Market is segmented as:
- Neurorobotic Systems
- Brain-computer Interface
- Wearable Devices
- Brain Stimulators
- Brain & Spinal Cord Injury
- Parkinson’s Disease
- Cerebral Palsy
- Multiple Sclerosis
By End User
- Rehabilitation Centers
- Hospitals & Clinics
- Home Care
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- North Africa
- South Africa
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America